​

2019-2020

HEOR Consultant for MAP BioPharma Ltd (UK)

Position as Lead Health Economist consultant.

Development of:

• Three NICE submissions for drugs for rare diseases 

• One SMC submission 

• Three Budget Impact model developed

• Mentoring of Health Economists and Market Access consultants and associates

• Six Health Economics models

• Supporting the development of outcomes for QALYs (DCE, Vignettes study using TTO)

• Two scientific advices for CADTH and NICE

• Research activity on NICE appraisals for orphan drugs 

• Participation at ISPOR 2019 conference in Copenhagen (Denmark) 

​

2019    

Consultant for the project “Health Technology Assessment of Trumenba vaccine for Meningitis B in Italy”    University of Genoa and University of Florence (Italy)

​

2018

Consultant for the project “Methodology for the Health Economic evaluation of Meningococcal vaccines”    Pfizer International, Paris (France)

2015  

Consultant for the development of "Pneumorischio App", a smartphone app to calculate the potential risk of invasive pneumococcal disease,    University of Genoa (Italy), University of Florence (Italy) - click here for info 

2015-2016  

Consultant for research project “Platelet Rich Plasma (PRP): an economic evaluation for Italian health care market”    University of Venice Ca’ Foscari (Italy) and RegenLab (Switzerland)

2011-2013    

Consultant for the research project “Methods to support decision for hospital treatment of surgeries based on Thyroids pathologies”    University of Genoa (Italy)

2009-2010    

Consultant for the research project “How to join efficiency and quality of care: new models and quantitative methods for the reorganization of health care services”.    Department of Economics., University of Genoa (Italy)

2006-2007    

Consultant for research project on Surgical Waiting List Info System and management (SWALIS 2)    University of Genoa (Italy)